The Ottawa Hospital Research Institute reports that the national network called the NeuroMuscular Disease for Canada (NMD4C) continues to gain momentum increasing the ability of providers to diagnose neuromuscular diseases, opening the door to earlier and better treatment. Canadian researchers materially impact this network via its Steering Committee. NMD4C recently received $1.2 million from the Canadian Institutes of Health Research (CIHR) and Muscular Dystrophy Canada for three years of operation. The public/private funds will help NMD4C advance research and collaboration on a variety of targets including Duchene muscular dystrophy, spinal muscular atrophy and myotonic dystrophy as well as many other rare genetic neuromuscular diseases, which collectively affect more than 64,000 Canadians.
As reported recently by Ottawa Hospital Research institute’s Newsroom, NMD4C plans on developing tools for better collaborative research, such as a pan-Canadian biobanking infrastructure to enable researchers to find the samples they require for their studies. Moreover, they seek to better support researchers to translate new findings into practice in clinics across Canada, including The Ottawa Hospital’s New NeuroMuscular Centre.
Dr. Hanns Lochmüller, a neurologist and senior scientists at CHEO Research Institute, associate scientist and neurologist at The Ottawa Hospital and professor at the University of Ottawa Brain and Mind Research Institute, noted, “Working together at a national level will help us rapidly develop new treatments for neuromuscular disease and give all Canadian patients access to world-class care”
The Ottawa Hospital Research Institute
This non-profit academic research institute is located in the city of Ottawa. Formed in 2001 via the merger of three Ottawa hospitals, it is the formal research arm of The Ottawa Hospital and affiliated with the University of Ottawa. The organization house over 550 scientists and clinical investigators with a focus on cancer therapeutics, chronic disease, clinical epidemiology, regenerative medicine and neuroscience.
The NMD4C is a network utilizing Canadian neuromuscular disease healthcare professionals, researchers and patients. NMD4C, a new network bringing together Canada’s leading clinical, scientific, technical and patient expertise in neuromuscular disease, seeks to improve care, research and treatment of neuromuscular disease for all Canadians.
Lead Researchers/Investigators with Ottawa Hospital Research Institute